| Value | ₹7.31 Cr |
|---|
BSE filing, NSE: MERCURYLAB. Summary written from the filing by ALFA Finder's alert engine.
Mercury Laboratories Ltd: key numbers
- Share price
- ₹749.95
- Market cap
- ₹89.99 Cr
- Revenue (annual)
- ₹75.94 Cr
- Net profit (annual)
- ₹4.83 Cr
- P/E (TTM)
- 21.6×Sector 46.1×
- Promoter holding
- 73.66%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Mercury Laboratories Ltd
All →Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Mercury Laboratories Management Change
Mercury Laboratories disclosed the cessation of Manager-HR Jaydeepsinh Raj, effective October 28, 2026. The employee stopped reporting for duty without prior intimation to the company.
Mercury Laboratories Other Announcement
Mercury Laboratories Ltd has filed its quarterly shareholding pattern under Regulation 31(1)(b). The report provides a standard breakdown of the company's current equity ownership structure.
Mercury Laboratories Management Change
Mr. Dilip Ramanlal Shah has ceased to be a Non-Executive Director of Mercury Laboratories Limited following the non-approval of his re-appointment at the recent AGM.
Mercury Laboratories Annual General Meeting
Mercury Laboratories Limited conducted its 45th Annual General Meeting on September 28, 2026. Shareholders considered agenda items including financial statements adoption and a ₹3.50 per share dividend.
Mercury Laboratories Management Change
Mercury Laboratories has appointed Mr. Jaydeepsinh Raj as Manager-HR, effective September 03, 2026.
Other debt & borrowing announcements
All →Fusion Finance Debt & Borrowing: ₹1.35 Cr
Fusion Finance Limited paid Rs.1.35 Crore monthly interest on its non-convertible debentures on 28 October 2026. The payment was made on time, one day ahead of the stated due date of 29 October 2026.
- Value
- ₹1.35 Cr
Bajaj Finance Debt & Borrowing: ₹300 Cr
Bajaj Life Insurance purchased 30,000 NCDs of Bajaj Finance worth ₹300 Crore on NSE. The open-market debt buy signals promoter confidence in the company.
- Value
- ₹300.0 Cr
Fusion CX Debt & Borrowing: ₹21.85 Cr
Fusion CX lent up to Rs.21.85 Crore (USD 2.3 million) to wholly owned subsidiary Fusion BPO Services. Terms: 8.5% interest, three-year tenure, unsecured.
- Value
- ₹21.85 Cr
- Execution
- 3 years from the date of disbursal
Fusion CX Debt & Borrowing
Fusion CX Limited executed an unsecured inter-corporate term loan at 8.5% p.a. for three years with its wholly owned subsidiary Fusion BPO Services Ltd, a related party. Amount is not stated in the filing.
- Execution
- 3 years from the date of disbursal
Spandana Sphoorty Financial Debt & Borrowing: ₹0.49 Cr
Spandana paid ₹0.49 Crore of quarterly interest on its secured NCDs on 27 October 2026. The coupon rate is 10.75% on a ₹50 Crore issue.
- Value
- ₹0.49 Cr
Mangalam Worldwide Debt & Borrowing: ₹1.14 Cr
Mangalam Worldwide paid Rs. 1.14 Crore interest on its NCDs (ISIN INE0JYY07026) on 28 October 2026, net of TDS. The company confirmed timely payment under Regulation 57.
- Value
- ₹1.14 Cr